白三烯受体拮抗剂在支气管哮喘中的应用被引量：3

下载PDF

导出

摘要目的探讨白三烯受体拮抗剂(顺尔宁)治疗支气管哮喘的疗效。方法2006年8月-2007年2月支气管哮喘患者96例随机分为常规治疗组48例及顺尔宁组48例。常规治疗组给予多索茶碱0.2g/d静脉注射,加用舒利迭50μg/250μg,2次/d吸入,顺尔宁治疗组在上述治疗基础上加用顺尔宁10mg,1次/d,睡前口服,疗程3周的临床资料进行总结分析。结果顺尔宁组及常规治疗组治疗前后临床症状评分差异有统计学意义(P<0.05),两组FEV1占预计值的百分比治疗前后差异有统计学意义(P<0.05)。结论顺尔宁依从性好,减少糖皮质激素的使用量,较好控制哮喘的急性发作。

作者马胜喜

机构地区新乡市中心医院呼吸内科

出处《医药论坛杂志》 2008年第23期51-52,共2页 Journal of Medical Forum

关键词白三烯受体拮抗剂(顺尔宁) 支气管哮喘治疗

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献4

1中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量：3564
2郑春盛,林青,林丽婷,江敏.小儿哮喘与白三烯关系的研究(附109例分析)[J].福建医药杂志,2003,25(3):167-169. 被引量：86
3董琳.白三烯受体拮抗剂的作用机制及临床应用的研究进展[J].中华儿科杂志,2005,43(4):266-268. 被引量：110
4慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量：5103

二级参考文献41

1Dent G, Ruhlmdnn E, Bodtake K, et al, Up-regulation of human eosinophilia leukotriene C4 generation through contact with bronchial ephithelial cell. Inflamm Res, 2000, 49 (5): 236-239.
2Drazen JM. Effects of cysteiny leukotrienes on human airways. In Holgate S, Dahlen SE (ed). SRS-A to leukotrienes. Oxford:Blackwell Science, 1997: 189-201.
3Laitinen LA, laitinen A, Haahtela T, et al. Leutriene E4 and granulocytic infiltration into asthmatic airways. Lancet, 1993, 341 :989-990.
4Wang CG, Du T, Xu LJ, et al. Role of leukotriene D4 in allergeninduced in airway smooth muscle in the rat. Am Rev Respir Dis,1993, 148: 413-417.
5Fregonese L, Silvestri M, Sabatini F, et al. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a Cys-LTI receptor mediated mechanism. Clin Exp Allergy, 2002, 32: 745-750.
6Braccioni F, Dorman SC, O′ byrne PM, et al. The effect of cysteinyl leukotrenes on growth of eosinophil proge from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol, 2002, 110:96-101.
7Murray J, Ward c, O′ Flaberty JT, et al. Role of leukotrenes in the regulation of human granulecyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Br J Pharmacol, 2003, 139:388-398.
8Henderson WR Jr, Tang LO, Chu SJ, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med, 2002, 165:108-116.
9Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum ECP, sIL-2R, IL-4, and sICAM-1 in children with asthma. J Allergy Clin Immunol, 2002,109: 257-263.
10Stelmach I, Grzelewski T, Stelmach W, et al. Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children. Pol Merkuriusz Lek, 2002,12:208-213.